3月 2026
sentibio.com
顯示 Similarweb 的估計資料。
透過連接你的 GA4 公開驗證你網站的指標
反映您的成功
連接 Google Analytics,認證您網站的流量和參與度指標
跳出率
42.49%
每次訪問頁數
1.83
平均訪問時長
00:00:14
sentibio.com 的前十大競爭對手
在 3月 2026,系統根據關鍵字流量、受眾定位與市場重疊率與 sentibio.com 的相似程度,排名出 sentibio.com 等前 10 名網站。
– Affini-T will leverage ElevateBio BaseCamp's LentiPeakTM lentiviral vector technology platform and cell product manufacturing capabilities to progress its
- 行業
- N/A
跳出率
32.68%
每次訪問頁數
2.30
平均訪問時長
00:00:46
相似度評分
100%Privacy policy This Privacy Policy describes the privacy practices of Erasca, Inc. (“Erasca”, “we”, “us” or “our”). Protecting the privacy and security of your personal information is important to Erasca. This Privacy Policy is designed to help you understand what data Erasca may collect, how Erasca uses and safeguards that data and who we may […]
- 公司介紹
- Erasca
跳出率
44.78%
每次訪問頁數
1.93
平均訪問時長
00:01:46
相似度評分
97%European laws, including the General Data Protection Regulation (“GDPR”) and the e-Privacy Directive 2002/58/EC, create obligations for digital publishers such as Inozyme Pharma (“Inozyme”) to give visitors of their sites and apps information about how they will use and share their personal data, as well as about the use of cookies, mobile ad IDs, and […]
- 公司介紹
- Inozyme
- 行業
- N/A
全球排名
- -
國家/地區排名
- -
同類排名
- -
跳出率
85.48%
每次訪問頁數
1.59
平均訪問時長
00:00:51
相似度評分
95%Kollab announced the acquisition of Senti AI, the pioneering artificial intelligence company in the Philippines. The acquisition of Senti AI coincides with Kollab's 10th year anniversary and reinforces their commitment to becoming a leading provider of AI-first and cloud-first solutions in the Philippines and across Southeast Asia.
- 公司介紹
- - -
- 行業
- - -
跳出率
41.08%
每次訪問頁數
1.74
平均訪問時長
00:00:45
相似度評分
89%The modern scientific enterprise is in the age of data science, utilizing advancing tools like computational biology, machine learning & AI.
跳出率
49.59%
每次訪問頁數
1.97
平均訪問時長
00:01:55
The recent invalidation of an AAV gene therapy patent overlooks the complexity of innovation in biotechnology and could put a broad swath of intellectual property at risk.
- 公司介紹
- - -
- 行業
- - -
跳出率
66.8%
每次訪問頁數
2.19
平均訪問時長
00:01:49
相似度評分
84%Learn about Kite’s mission to change the way cancer is treated with cell therapy – the use of genetically modified immune cells programmed to target tumors.
跳出率
45.79%
每次訪問頁數
1.63
平均訪問時長
00:00:54
The extraordinary general meeting (“EGM”) of the shareholders of CureVac N.V. will take place on Tuesday, March 28, 2023, starting from 2 p.m. Central European Summer Time.
- 公司介紹
- CureVac
跳出率
43.7%
每次訪問頁數
1.43
平均訪問時長
00:00:21
相似度評分
79%Transforming disease treatment through cell and gene therapy. Join us at BlueRock to discover our cutting-edge science & clinical programs.
- 公司介紹
- BlueRock
跳出率
49.47%
每次訪問頁數
1.70
平均訪問時長
00:00:45
sentibio.com 在 3月 2026的前 5 大競爭對手是:affinittx.com、erasca.com、inozyme.com、regenxbio.com 等。
根據 Similarweb 月造訪量數據,sentibio.com 在 3月 2026 的主要競爭對手為 affinittx.com。與 sentibio.com 相似度排名第二的網站是 erasca.com,緊隨其後位居前三的是 inozyme.com。
在 3月 2026,regenxbio.com 被評為與 sentibio.com 相似度第四高的網站,senti.ai 則位居第五。
前十名榜單中的其他五家競爭對手分別是 sbpdiscovery.org、biospace.com、kitepharma.com、curevac.com 和 bluerocktx.com。